Big Pharma Whistleblower Awarded $1.6 Million for Exposing Cancer Drug Medicare Fraud

Email this article to a friend

Printable Version

Articles Related to This Article: • Medicare to fund obesity treatments, but which ones really work? • Medicare payments to doctors to be slashed; AMA panics as more doctors drop Medicare patients • Medicare drug plan was bait-and-switch scheme; plan prices to skyrocket next year Support NaturalNews advertisers - Advertise with NaturalNews Help support NaturalNews with health books and educational programs from Truth Publishing: • Swine Flu Advanced Preparedness • 8 Weeks to Vibrant Health • Raw In Ten Minutes (recipes) • How to Halt Diabetes in 25 Days ... and much more.

(NaturalNews) A federal judge has awarded a whistleblower $1.6 million for tipping off federal prosecutors to a scheme by pharmaceutical company Cell Therapeutics to illegally promote unapproved uses of the cancer drug Trisenox.

Prosecutors argued against granting whistleblower James Marchese any portion of the $10.5 million settlement that Cell Therapeutics agreed to pay. Typically, whistleblowers are entitled to between 15 and 25 percent of any funds received by the government, unless they were the initiator or planner of the offense.

The offense in question involved defrauding Medicare by promoting unauthorized uses of Trisenox. Among Marchese's actions in furtherance of the fraud was getting unapproved uses of the drug listed in cancer journals, then writing letters to Medicare directors citing those listings as proof that such uses of Trisenox should be reimbursable.

But Marchese said that he was only a low-level employee acting on the orders of his supervisors, and that he risked his job by going to the government. Marchese and his lawyers asked for the full 25 percent, or $2.6 million, saying that without him the government would have had no case.

Instead, Judge Marsha J. Pechman instead awarded him the minimum, 15 percent. She ruled that he was not an initiator of the scheme, and that in its early phases he believed his actions to be legal. But she scolded him for waiting so long to come forward after realizing that the company was committing fraud, even as patients continued to be placed at risk by the company's actions.

According to the court, Marchese became angry after being passed over for a promotion, at which point he wrote a letter to his superiors taking credit for the Medicare scam. Only after another confrontation with his superiors did Marchese eventually go to the authorities, in October 2002.

By settling the case, Cell Therapeutics avoided admitting to or being convicted of any crime.

Share

Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Medicare to fund obesity treatments, but which ones really work? • Medicare payments to doctors to be slashed; AMA panics as more doctors drop Medicare patients • Medicare drug plan was bait-and-switch scheme; plan prices to skyrocket next year	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/023554_medicare_cancer_Big_Pharma.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/023554_medicare_cancer_Big_Pharma.html">Big Pharma Whistleblower Awarded $1.6 Million for Exposing Cancer Drug Medicare Fraud</a>